Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1999
11/09/1999US5981193 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
11/09/1999US5981192 Hybridizing complementary nucleotide sequences, removing unhybridized portion, detecting said hybridization complex; diagnosis of cancer and immune diseases
11/09/1999US5981189 Contacting the sample with a nucleotide probe capable of hybridizing with nucleic acid sequence, detecting hybridization product; diagnostic tool in detection of diarrhea from campylobacter
11/09/1999US5981181 DNA sequences with oligosaccharide transporter, plasmids bacteria and plants containing a transporter as well as a process for the preparation and transformation of yeast strains for identification of the transporter
11/09/1999US5981178 Diagnosing cystic fibrosis in vitro to determine if human subject is carrier of the genetic disorder; obtaining sample and analyzing genetic composition
11/09/1999US5981173 Human urogenital virus dna; for diagnosis and for developing models for cancer of urogenital system
11/09/1999US5981172 Probe for viral untranslated region; detecting viral nucleic acids; deveolping vaccines and antibodies to use as diagnostic tool in detecting presence of virus
11/09/1999US5981170 Diagnostic immunoassay kit for detection of antibodies induced by human immunodeficiency virus in sample of body fluid; includes artificial peptide of an epitope having a cystine bridge
11/09/1999US5981165 Exogenous activation and expression of tyrosine hydroxylase in neural cells; culturing mammalian cells of central nervous system; treatment for parkinson's disease and other nervous system disorders
11/09/1999US5980913 A tetrapeptides as vaccine adjuvant
11/09/1999US5980911 Enhancing an immune synergy response to an antigen comprising the administration of at least two cytokines
11/09/1999US5980910 Useful in coating polymeric medical materials to prevent colonization by coagulase-negative staphylococcal strains, in assays for the detection of such bacteria
11/09/1999US5980909 Epitopic regions of pneumococcal surface protein A
11/09/1999US5980907 Use in immunoprophylaxis
11/09/1999US5980906 Live recombinant avian vaccine using an avian herpesvirus as vector
11/09/1999US5980901 Viral defective interfering particles and uses thereof
11/09/1999US5980899 Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells
11/09/1999US5980897 Treating mammals suffering from infections caused by gram-negative bacteria
11/09/1999US5980896 Antibodies reactive with human carcinomas
11/09/1999US5980892 Increasing cytotoxicity by exposing t lymphocytes to a monoclonal antibody, reacting with an epitope of the variable region of a t cell antigen receptor; treating rheumatoid arthritis
11/09/1999US5980891 Schizosaccharomyces-specific polypeptides
11/09/1999US5980885 Growth factor-induced proliferation of neural precursor cells in vivo
11/09/1999CA2136565C Polypeptide of protein p140 and dnas encoding it
11/09/1999CA1340817C Recombinant flagellin vaccines
11/09/1999CA1340816C Diagnostic test for pseudomonas aeruginosa infections
11/09/1999CA1340815C Hybridomas producing monoclonal antibodies to new mucin epitopes
11/08/1999CA2269148A1 Novel methods for the production of gelatin and full-length triple helical collagen recombinant cells
11/07/1999CA2270405A1 Polymorphisms associated with hypertension
11/04/1999WO1999056129A1 Methods of selecting internalizing antibodies
11/04/1999WO1999055915A2 IDENTIFICATION OF POLYMORPHISMS IN THE PCTG4 REGION OF Xq13
11/04/1999WO1999055910A1 Method of inducing apoptosis in a target cell
11/04/1999WO1999055908A2 Nucleotide sequences for detecting enterohemorrhagic escherichia coli (ehec)
11/04/1999WO1999055902A1 Diagnostic markers of human female infertility
11/04/1999WO1999055901A2 Screening assay for identifying human purinoreceptor ligands
11/04/1999WO1999055900A2 Gcp
11/04/1999WO1999055899A1 Methods for transducing fusion molecules
11/04/1999WO1999055893A1 Retroviral vectors including modified envelope escort proteins
11/04/1999WO1999055892A1 Use of triplex structure dna sequences for transferring nucleotide sequences
11/04/1999WO1999055891A1 Plant gene that regulates dna methylation
11/04/1999WO1999055885A2 Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein
11/04/1999WO1999055876A2 Polypeptide with immunogenic properties and with a protein with modified biological functions
11/04/1999WO1999055875A2 VACCINES CONTAINING RECOMBINANT PILIN AGAINST NEISSERIA GONORRHOEAE OR $i(NEISSERIA MENINGITIDIS)
11/04/1999WO1999055874A2 Nucleic acids of the m antigen gene of histoplasma capsulatum, antigens, vaccines and antibodies, methods and kits for detecting histoplasmosis
11/04/1999WO1999055873A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
11/04/1999WO1999055872A1 Basb013 dna and proteins from neisseria meningitidis
11/04/1999WO1999055871A1 Polypeptides from moraxella (branhamella) catarrhalis
11/04/1999WO1999055870A2 Transcription and gene expression regulators
11/04/1999WO1999055869A1 Novel polypeptide growth factors and materials and methods for making them
11/04/1999WO1999055868A2 Fizz proteins
11/04/1999WO1999055867A1 Delayed rectifier potassium channel subunit
11/04/1999WO1999055865A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999WO1999055864A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF
11/04/1999WO1999055863A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF
11/04/1999WO1999055862A2 Human proteins having transmembrane domains and dnas encoding these proteins
11/04/1999WO1999055861A2 Fibroblast growth factor mutein compositions and methods of use therefor
11/04/1999WO1999055860A1 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto
11/04/1999WO1999055859A2 Cd40-interacting and traf-interacting proteins
11/04/1999WO1999055858A2 Human nucleic acid sequences obtained from pancreas tumor tissue
11/04/1999WO1999055852A1 Apolipoprotein e transgenic animals and assay methods
11/04/1999WO1999055849A1 Tyrosine phosphatase ia-2, gad and rotavirus vp7 immunity
11/04/1999WO1999055844A2 Methods for modulating differentiation
11/04/1999WO1999055840A1 A transcription factor and method for regulation of seed development, quality and stress-tolerance
11/04/1999WO1999055839A1 Host defense enhancement
11/04/1999WO1999055835A1 Anti-vibrio anguillarum vaccine (gava-3) for the prevention of the vibriosis disease in the turbot and salmonidae, and preparation process
11/04/1999WO1999055832A2 Nucleic acid encoding rate agouti related protein
11/04/1999WO1999055735A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999WO1999055733A1 Cloning of a novel 7tm receptor axor-2
11/04/1999WO1999055732A1 A novel g-protein coupled receptor
11/04/1999WO1999055731A1 Peptide with endotoxin-neutralizing activity
11/04/1999WO1999055730A2 Polyepitope carrier protein
11/04/1999WO1999055728A2 Ese genes and proteins
11/04/1999WO1999055721A1 Secreted proteins and polynucleotides encoding them
11/04/1999WO1999055720A1 Targeted gene delivery to cells by filamentous bacteriophage
11/04/1999WO1999055718A2 Solution phase biopolymer synthesis
11/04/1999WO1999055716A1 A gene associated with nijmegen breakage syndrome, its gene product and methods for their use
11/04/1999WO1999055564A1 Materials and methods for gene therapy
11/04/1999WO1999055382A1 Adenoviral vector encoding anti-apoptotic bcl-2 gene and uses thereof
11/04/1999WO1999055381A1 Method and process for establishment of stage specific expression and characterization of proteins based on microbial or human genomic sequence data
11/04/1999WO1999055380A1 Nr-CAM GENE, NUCLEIC ACIDS AND NUCLEIC ACID PRODUCTS FOR THERAPEUTIC AND DIAGNOSTIC USES FOR TUMORS
11/04/1999WO1999055368A1 Regulation of biofilm formation
11/04/1999WO1999055367A1 INTERNALIZING ErbB2 ANTIBODIES
11/04/1999WO1999055366A1 Chimeras of hepatitis c virus and bovine viral diarrhea virus
11/04/1999WO1999055365A1 Adenoviral vectors with tandem fiber proteins
11/04/1999WO1999055364A2 Proteins that direct the secretion of virulence proteins and vaccines comprising them
11/04/1999WO1999055361A1 Neovascularization inhibitors
11/04/1999WO1999055343A1 Cnre binding factors and uses thereof
11/04/1999WO1999055310A1 Stabilized protein crystals, formulations containing them and methods of making them
11/04/1999WO1999055134A2 Compositions and methods for identifying apoptosis signaling pathway inhibitors and activators
11/04/1999WO1999055132A2 Generation of packaging system for human recombinant adenoviral vectors
11/04/1999WO1999047671A3 Dna sequences encoding semaphorin-h and diagnosis of metastatic cancer
11/04/1999WO1999046381A3 Human fgf gene and gene expression products
11/04/1999WO1999046377A3 A human vanilloid receptor-like cation channel
11/04/1999WO1999046372A3 Ribozymes capable of inhibiting the expression of the ccr5 receptor
11/04/1999WO1999045114A3 Human semaphorin zsmf-7
11/04/1999WO1999045112A3 Chromosome 11-linked coronary heart disease susceptibility gene chd1
11/04/1999WO1999042597A9 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
11/04/1999WO1999042585A9 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
11/04/1999WO1999042477A8 Transporter protein for saccharide-coupled medicaments
11/04/1999WO1999042473A9 Inhibition of toxin translocation
1 ... 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 ... 2916